Picture of Qinetiq logo

QQ. Qinetiq News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsBalancedMid CapNeutral

REG - QinetiQ Group plc - Result of Meeting

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240206:nRSF2050Ca&default-theme=true

RNS Number : 2050C  QinetiQ Group plc  06 February 2024

QINETIQ GROUP PLC

6 February 2024

QINETIQ GROUP PLC

Results of General Meeting held on 6 February 2024

Poll Results of General Meeting

QinetiQ Group plc (QinetiQ) announces that the resolution proposed as an
ordinary resolution at its General Meeting (GM) held on 6 February 2024 was
duly passed without amendment by the requisite majority of shareholders and
the results of the poll are as follows:

                                                                              VOTES FOR    %      VOTES AGAINST  %     TOTAL VOTES VALIDLY CAST  % OF SHARE CAPITAL WITH VOTING RIGHTS  VOTES WITHHELD
 1  To authorise the Company to make market purchases of its ordinary shares  485,836,928  99.51  2,371,173      0.49  488,208,101               84.35                                  688,113
    pursuant to section 701 of the Companies Act 2006

Notes:

1.       The percentages above are rounded to two decimal places.

2.       Votes "for" include discretionary votes.

3.       A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "for" and "against" a resolution.

4.       The number of ordinary shares in issue at 6.30pm on 2 February
2024 was 578,757,121 of which none are held in treasury. Therefore the number
of ordinary shares with voting rights at 6.30pm on 2 February 2024 was
578,757,121.

Results of the poll can also be viewed on QinetiQ's website:
https://www.qinetiq.com/en/investors/shareholder-services/agm
(https://www.qinetiq.com/en/investors/shareholder-services/agm)

Following the resolution being duly passed, the share buyback programme as
previously announced on 16 January 2024 (the Programme) will commence on 7
February 2024.

The first tranche of up to £50 million will be carried out through an
irrevocable non-discretionary agreement with Barclays Capital Securities
Limited (Barclays) on the basis set out in the announcement of the Programme
on 16 January 2024. Barclays may undertake transactions in QinetiQ shares
(which may include sales and hedging activities, in addition to purchases
which may take place on any available trading venue or an over the counter
basis) during the Programme in order to manage their market exposure under the
Programme. Disclosure of such transactions will not be made by Barclays as a
result of or part of the Programme, but Barclays will continue to make any
disclosures they are otherwise legally required to make.

In accordance with Listing Rule 9.6.2, a copy of the resolution will be
submitted to the National Storage Mechanism and will shortly be available for
inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

For further information please contact:

John Haworth, Group Director Investor
Relations:                      +44 (0) 7920 545841

Lindsay Walls, Group Director Communications:
          +44 (0) 7793 427582

James Field, Company
Secretary:
+44 (0) 7841 662957

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMFLFELFFIRIIS

Recent news on Qinetiq

See all news